The control of blood flow to the placenta

Experimental Physiology

Volumn 82, Issue 2, 1997, Pages 377-387

  Poston, Lucilla ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; ENDOTHELIN; NITRIC OXIDE; PROSTANOID; VASOACTIVE AGENT;

ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETER; FEMALE; FETUS; FETUS HEART; GROWTH RETARDATION; HEART OUTPUT; HUMAN; PLACENTA CIRCULATION; UMBILICAL ARTERY; VASCULAR RESISTANCE;

EID: 0030894164     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.1997.sp004033     Document Type: Article

References (48)

1. 2 by human umbilical vessels increases from the placenta towards the fetus. British Journal of Obstetrics and Gynaecology 94, 1165-1169.
2. BOURA, A. L. A. & WALTERS, W. A. W. (1991). Autacoids and the control of vascular tone in the human umbilical-placental circulation. Placenta 12, 453-477.
3. BUTTERY, L. D., MCCARTHY, A., SPRINGALL, D. R., SULLIVAN, M. H., ELDER, M. G. & POLAK, J. M. (1994). Endothelial nitric oxide in the human placenta; regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 15, 257-265.
4. CHARD, T. (1972). The posterior pituitary in human and animal reproduction. Journal of Reproduction and Fertility 16, 121-138.
5. CHARD, T., HUDSON, C. N., EDWARDS, C. R. W. & BOYD, N. R. H. (1971). Release of oxytocin and vasopressin by the human foetus during labour. Nature 234, 352-354.
6. CLIFTON, V. L., READ, M. A., BOURA, A. L., ROBINSON, P. J. & SMITH, R. (1996). Adrenocorticotropin causes vasodilatation of the human fetal-placental circulation. Journal of Clinical Endocrinology and Metabolism 81, 1406-1410.
7. CLIFTON, V. L., READ, M. A., LEITCH, I. M., GILES, W. B., BOURA, A. L., ROBINSON, P. J. & SMITH, R. (1995). Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′5′-monophosphate-mediated pathway. Journal of Clinical Endocrinology and Metabolism 80, 2888-2893.
8. COHN, H. E., SACKS, E. J., HEYMANN, M. A. & RUDOLPH, A. M. (1974). Cardiovascular responses to hypoxaemia and acidaemia in fetal lambs. American Journal of Obstetrics and Gynecology 120, 817-824.
9. DIXON, W. G., TRIBE, R. M., PALMER, A. M., LINTON, E. A. & POSTON, L. (1996). Corticotropin releasing hormone (CRH) does not relax isolated human fetoplacental resistance arteries. Journal of the Society of Gynecologic Investigation 3, 235A.
10. EIK-NES, S. H., MARSAL, K. & KRISTOFFERSEN, K. (1984). Methodology and basic problems related to blood flow studies in the human fetus. Ultrasound in Medicine and Biology 10, 329-337.
11. ERSKINE, R. L. A. & RITCHIE, J. W. K. (1985). Umbilical artery blood flow characteristics in normal and growth retarded fetuses. British Journal of Obstetrics and Gynaecology 92, 605-610.
12. FABER, J. J. & THORNBERG, K. L. (1983). Placental Physiology, 1st edn. Raven Press, New York.
13. GERSON, A. G., WALLACE, D. M., STILLER, R. J., PAUL, D., WEINER, S. & BOLOGNESE, R. J. (1987). Doppler evaluation of umbilical venous and arterial blood flow in the second and third trimesters of normal pregnancy. Obstetrics and Gynecology 70, 622-626.
14. GHABOUR, M. S., EIS, A. L. W., BROCKMAN, D. E., POLLOCK, J. S. & MYATT, L. (1995). Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia. American Journal of Obstetrics and Gynecology 173, 687-94.
15. HAEGERSTRAND, A., HEMSEN, A., GILLIS, C., LARSSON, O. & LUNDBERG, J. M. (1989). Endothelin: presence in human umbilical vessels, high levels in fetal blood and potent constrictor effect. Acta Physiologica Scandinavica 137, 541-542.
16. HAKKINEN, L. M., VUOLTEENAHO, O. J., LEPPALUOTO, J. P. & LAATIKAINEN, T. J. (1992). Endothelin in maternal and umbilical cord blood in spontaneous labor and at elective cesarean delivery. Obstetrics and Gynecology 80, 72-75.
17. HALPERN, W. & KELLY, M. (1991). In vitro methodology for resistance arteries. Blood Vessels 72, 1276-1284.
18. KAUFMANN, P. (1982). Development and differentiation of the human placental villous tree. Bibliotheca Anatomica 22, 29-39.
19. KINGDOM, J. C. P., MCQUEEN, J., CONNELL, J. M. C. & WHITTLE, M. J. (1992). Maternal and fetal atrial natriuretic peptide levels at delivery from normal and growth retarded pregnancies. British Journal of Obstetrics and Gynaecology 99, 845-849.
20. KREBS, C., MACARA, L. M., LEISER, R., BOWMAN, A., CREER, I. A. & KINGDOM, J. C. P. (1996). Absent end diastolic flow in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Americal Journal of Obstetrics and Gynecology (in the Press).
21. LAURIN, J., LINGMAN, G., MARSAL, K. & PERSSON, P.-H. (1987). Fetal blood flow in pregnancies complicated by uterine growth retardation. Obstetrics and Gynecology 69, 896-902.
22. LEARMONT, J. G. & POSTON, L. (1996). Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries. American Journal of Obstetrics and Gynecology 174, 583-588.
23. LINTON, E. A., PERKINS, A. V., WOODS, R. J., EBEN. F., WOLFE, C. D., BEHAN, D. P., POTTER, E., VALE, W. W. & LOWRY, P. J. (1993). Corticotropin-releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal pregnancy. Journal of Clinical Endocrinology and Metabolism 76, 260-263.
24. LYALL, F., GREER, I. A., YOUNG, A. & MYATT, L. (1996). Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta 17, 165-168.
25. MCCARTHY, A. L., WOOLFSON, R. G., EVANS, B., DAVIS, D. R., RAJU, S. K. & POSTON, L. (1994). Functional characteristics of small placental arteries. American Journal of Obstetrics and Gynecology 170, 945-951.
26. MACLEAN, M. R., TEMPLETON, A. G. B. & MCGRATH, J. C. (1992). The influence of endothelin-1 on human foeto-placental blood vessels: a comparison with 5-hydroxytryptamine. British Journal of Pharmacology 106, 937-941.
27. MCQUEEN, J., KINGDOM, J. C. P., WHITTLE, M. J. & CONNELL, J. M. C. (1993). Characterization of atrial natriuretic peptide receptors in human fetoplacental vasculature. American Journal of Physiology 264, H798-804.
28. MAIGAARD, S., FORMAN, A. & ANDERSSON, K. E. (1986a). Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit. Acta Physiologica Scandinavica 128, 23-31.
29. MAIGAARD, S., FORMAN, A. & ANDERSSON, K. E. (1986b). Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit. Acta Physiologica Scandinavica 128, 33-40.
30. MALAMITSI-PUCHNER, A., ANTSAKLIS, A., ECONOMOU, E., MESOGITIS, S., PAPANTONIOU, N., KOUTRA, N. & ARAVANTINOS, D. (1995). Endothelin 1-21 plasma levels in fetuses at 18-24 weeks of gestation. Journal of Perinatal Medicine 23, 321-325.
31. MOMBOULI, J. V., LE, S. Q., WASSERSTRUM, N. & VANHOUTTE, P. M. (1993). Endothelins 1 and 3 and big endothelin-1 contract isolated human placental veins. Journal of Cardiovascular Pharmacology 22, suppl. 8, S278-281.
32. MULVANY, M. J. & HALPERN, W. (1977). Contractile properties of small arterial resistance arteries in spontaneously hypertensive and normotensive rats. Circulation Research 41, 19-26.
33. MYATT, L., BREWER, A. & BROCKMAN, D. E. (1991). The action of nitric oxide in the perfused human fetal-placental circulation. American Journal of Obstetrics and Gynecology 164, 687-692.
34. MYATT, L., BROCKMAN, D. E., EIS, A. L. W. & POLLOCK, J. S. (1993). Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14, 487-495.
35. OHNO, Y., MIZUTANI, S., KURAUCHI, O., NISHIDA, Y., ARII, Y. & TOMODA, Y. (1995). Umbilical plasma concentration of endothelin-1 in intrapartum fetal stress: effect of heart rate abnormalities. Obstetrics and Gynecology 86, 822-825.
36. PANOS, K. N., NICOLAIDES, K. H., ANDERSON, J. V., ECONOMIDES, D. L., REES, L. & WILLIAMS, R. (1989). Plasma atrial natriuretic peptide in the human fetus: response to intravascular blood transfusion. American Journal of Obstetrics and Gynecology 161, 357-361.
37. PERKINS, A. V. & LINTON, E. A. (1995). Identification and isolation of corticotrophin-releasing hormone-positive cells from the human placenta. Placenta 16, 233-243.
38. RITTER, J. M., ONGARI, M. A., BARROW, S. E., ORCHARD, M. A., BLAIR, I. A. & LEWIS, P. J. (1982). Prostanoid synthesis by the human umbilical artery. Prostaglandins 24, 881-886.
39. RUTHERFORD, R. A., WHORTON, J., MCCARTHY, A., GORDON, L., SULLIVAN, M. H., ELDER, M. G. & POLAK, J. M. (1993). Differential localisation of ETA and ETB binding sites in human placenta. British Journal of Pharmacology 109, 544-552.
40. SVANE, D., KAHR, O., HANSEN, V. B., HOLM-NIELSEN, P. & FORMAN, A. (1995). Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries. American Journal of Obstetrics and Gynecology 172, 991-997.
41. TEMPLETON, A. G. B., MCGRATH, J. C. & WHITTLE, M. J. (1991). The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT, and 5-CT in the human isolated umbilical artery. British Journal of Pharmacology 103, 1079-1084.
42. TENCE, M. & PETIT, A. (1989). Characterization of angiotensin II binding sites in the human term placenta. Molecular and Cellular Endocrinology 63, 111-119.
43. THOMPSON, R. S. & TRUDINGER, B. K. (1990). Doppler waveform pulsatility index and resistance, pressure and flow in the umbilical placental circulation: An investigation using a mathematical model. Ultrasound in Medicine and Biology 16, 449-458.
44. TRUDINGER, B. J. (1993). Doppler ultrastenography: applications. In Fetus and Neonate. Physiology and Clinical Implications, ed. HANSON, M. A., SPENCER, J. A. D. & HANSON, C. H., pp. 323-338. Cambridge University Press, Cambridge, UK.
45. WHITE, R. P. (1989). Pharmacodynamic study of maturation and closure of human umbilical arteries. American Journal of Obstetrics and Gynecology 160, 229-237.
46. WIGGLESWORTH, J. S. (1969). Vascular anatomy of the human placenta and its significance for placental pathology. Journal of Obstetrics and Gynaecology of the British Commonwealth 76, 979-989.
47. WOLFE, C. D. A., PATEL, S. P., LINTON, E. A., CAMPBELL, E. A., ANDERSON, J., DORNHURST, A., LOWRY, RJ. & JONES, M. T. (1988). Plasma corticotrophin-releasing factor (CRF) in abnormal pregnancy. British Journal of Obstetrics and Gynaecology 95, 1003-1006.
48. WOOD, C. E. (1993). Local and endocrine factors in the control of the circulation. In Fetus and Neonate. Physiology and Clinical Implications, ed. HANSON, M. A., SPENCER, J. A. D. & HANSON, C. H., pp. 110-115. Cambridge University Press, Cambridge, UK.